ID   BTT-T739
AC   CVCL_M626
SY   BTT T739; T739
DR   Wikidata; Q54798609
RX   PubMed=23691487;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: T739.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 7
//
RX   PubMed=23691487; DOI=10.7497/j.issn.2095-3941.2012.04.007; PMCID=PMC3643680;
RA   Yang, Xi-Hua
RA   Ren, Lian-Sheng
RA   Wang, Guo-Ping
RA   Zhao, Li-Li
RA   Zhang, Hong
RA   Mi, Zhen-Guo
RA   Bai, Xi-Hua
RT   "A new method of establishing orthotopic bladder transplantable tumor
RT   in mice.";
RL   Cancer Biol. Med. 9:261-265(2012).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon, Tahlita C.M.
RA   de Jong, Florus Christiaan
RA   Costello, James C.
RA   Theodorescu, Dan
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//